unique clonal jak2 mutation leading constitutive signalling causes polycythaemia vera 
myeloproliferative disorders clonal haematopoietic stem cell malignancies characterized independency hypersensitivity haematopoietic progenitors numerous cytokines12 molecular basis myeloproliferative disorders unknown basis model chronic myeloid leukaemia expected constitutive tyrosine kinase activity origin diseases polycythaemia vera acquired myeloproliferative disorder characterized presence polycythaemia diversely associated thrombocytosis leukocytosis splenomegaly3 polycythaemia vera progenitors hypersensitive erythropoietin cytokines45 describe clonal recurrent mutation jh2 pseudo-kinase domain janus kinase jak2 gene >% polycythaemia vera patients mutation valine-to-phenylalanine substitution amino acid position leads constitutive tyrosine phosphorylation activity promotes cytokine hypersensitivity induces erythrocytosis mouse model mutation also found myeloproliferative disorders unique mutation will permit new molecular classification disorders novel therapeutical approaches 
